Oncotype Dx use and its relationship with chemotherapy administration in the general population

被引：0
作者：
Chavez-MacGregor, Mariana [1 ]
Niu, Jiangong [1 ]
Smith, Benjamin [1 ]
Zhao, Hui [1 ]
Buchholz, Thomas A. [1 ]
Giordano, Sharon H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-05
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007
    Dinan, Michaela Ann
    Mi, Xiaojuan
    Reed, Shelby D.
    Hirsch, Bradford Richard
    Lyman, Gary H.
    Curtis, Lesley H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
    Casasanta, Nicole
    Kipnis, Sarit T.
    Linville, Laura
    Lipinski, Shawn
    Knoedler, Alice
    Marino, Amy
    McHenry, Allision
    Biagi, Tara
    Stark, Elizabeth
    Amdur, Richard
    Denduluri, Neelima
    Rodriguez, Patricia
    Isaacs, Claudine
    Kaltman, Rebecca
    CLINICAL BREAST CANCER, 2020, 20 (02) : 125 - 130
  • [33] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Enewold, Lindsey
    Geiger, Ann M.
    Zujewski, JoAnne
    Harlan, Linda C.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 149 - 156
  • [34] The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer
    Rabie, M. A.
    Rankin, A.
    Burger, A.
    Youssef, M. M. G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (08) : 596 - 601
  • [35] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Lindsey Enewold
    Ann M. Geiger
    JoAnne Zujewski
    Linda C. Harlan
    Breast Cancer Research and Treatment, 2015, 151 : 149 - 156
  • [36] Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer
    Yahiya Y. Syed
    Molecular Diagnosis & Therapy, 2020, 24 : 621 - 632
  • [37] COST-EFFECTIVENESS ANALYSIS OF THE USE OF ONCOTYPE DX TO GUIDE ADJUVANT CHEMOTHERAPY DECISIONS IN BREAST CANCER PATIENTS IN MEXICO
    Plun-Favreau, J.
    Suarez, S.
    Chivardy, H.
    Pozo, L.
    VALUE IN HEALTH, 2013, 16 (03) : A140 - A140
  • [38] Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center
    Katya Losk
    Rachel A. Freedman
    Alison Laws
    Olga Kantor
    Elizabeth A. Mittendorf
    Zhenying Tan-Wasielewski
    Lorenzo Trippa
    Nancy U. Lin
    Eric P. Winer
    Tari A. King
    Breast Cancer Research and Treatment, 2021, 185 : 215 - 227
  • [39] Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center
    Losk, Katya
    Freedman, Rachel A.
    Laws, Alison
    Kantor, Olga
    Mittendorf, Elizabeth A.
    Tan-Wasielewski, Zhenying
    Trippa, Lorenzo
    Lin, Nancy U.
    Winer, Eric P.
    King, Tari A.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 215 - 227
  • [40] The Oncotype DX® assay use in breast cancer in an Australian institutional setting
    Choi, J. D. W.
    Hughes, T. M. D.
    Marx, G.
    Boyages, J.
    Rutovitz, J.
    Hasovits, C.
    Parasyn, A.
    Edirimanne, S.
    Ngui, N. K.
    BREAST, 2021, 56 : S66 - S67
12345